Investing.com — 周二，Stifel分析师维持了对Trevi Therapeutics (NASDAQ: TRVI )的积极立场，重申买入评级，目标价为15美元。这与更广泛的分析师共识一致，根据 InvestingPro 数据显示，分析师目标价在11美元至29美元之间，最近有五位分析师上调了其盈利预期。这一认可是在Trevi Therapeutics分享了其RIVER ...

CANBERRA, May 20 (Xinhua) -- One in eight Australians can't identify the location of the Great Barrier Reef, despite its global fame and environmental importance, according to new research from the ...

Modern life makes us tired, right? But research from societies in Africa and South America suggests people in the ancient ...